Table 1.
Age, y | 64 (mean) | |
Sex | N (%) | |
Male | 21 (52.5%) | |
Female | 19 (47.5%) | |
Race | N | |
White | 13 | |
Black | 16 | |
Hispanic-white | 11 | |
Hispanic-nonwhite | 0 | |
Other | 0 | |
History of stroke/TIA | N (%) | |
TIA | 2 | |
Infarct | 9 | |
ICH | 0 | |
NIHSS score (mean) | ||
Admission | 6 | |
24 h | 4 | |
Discharge/day 7 | 3 | |
Time to presentation | ||
Male | 523 min | |
Female | 586 min | |
Symptom onset to Rx | ||
Mean | 12 h 32 min | |
Median | 8 h 25 min | |
Admission glucose | 153 (mean) | |
Length of stay | 4.75 days | |
Current antithrombotic use | N (%) | |
Aspirin | 3 (7.5%) | |
Clopidogrel | 1 (2.5%) | |
Aggrenox | 2 (5.0%) | |
Warfarin | 1 (2.5%) | |
None | 33 (82.5%) | |
Time to presentation, | N (%) | |
0-3 h | 7 (17.5%) | |
3 h 1 min-6 h | 11 (27.5%) | |
6 h 1 min-12 h | 7 (17.5%) | |
12 h 1 min-24 h | 15 (37.5%) | |
Discharge disposition | N (%) | |
Home | 26 (65.0%) | |
Inpatient rehabilitation | 8 (20.0%) | |
Skilled nursing facility | 2 (5.0%) | |
Nursing home | 1 (2.5%) | |
Other | 2 (5.0%) | |
NIHSS score on presentation | N (%) | |
0 | 6 (15%) | |
1-5 | 18 (45%) | |
6-10 | 9 (22%) | |
11-15 | 4 (10%) | |
16-20 | 1 (3%) | |
>20 | 2 (5%) |
ICH, intracranial hemorrhage; NIHSS, National Institutes of Health stroke scale; Rx, prescription; TIA, transient ischemic attack.